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Background: The interaction between Src homology 2 domain-containing protein tyrosine phosphatase (SHP-2) of
gastric epithelial cells and cagA from H. pylori plays a crucial role in developments of gastric atrophy and gastric
cancer. This study aimed to investigate the association of haplotype tagging SNPs (htSNPs) in the PTPN11 gene
encoding SHP-2 with gastric atrophy and gastric cancer in Chinese population.
Methods: The subjects comprised 414 patients with gastric cancer, 109 individuals with gastric atrophy and 923
healthy controls. Blood was collected from October 2008 to October 2010. Five htSNPs rs2301756, rs12423190,
rs12229892, rs7958372 and rs4767860 from the PTPN11 gene were selected and genotyped by Taqman assay.
Serum Ig G antibodies to H. pylori were detected by ELISA. Gastric atrophy was screened by the levels of serum
pepsinogenIandII, and confirmed by endoscopy and histopatholgical examinations. Odds ratio (ORs) and 95%
confidence intervals (CIs) were calculated by a multivariate logistic regression.
Results: Among H. pylori seropositive subjects, age and gender-adjusted OR of gastric atrophy was 2.47 (95%CI
1.13-4.55, P= 0.02) for CC genotype compared with CT/TT genotypes, suggesting a recessive model of genetic risk
for rs12423190. The prevalence of H. pylori seropositivity were significantly higher in groups of gastric cancer and
gastric atrophy compared to the control group (70.3% vs. 75.2% vs. 49.7%, P <0.001). However, the distributions of
genotypes and haplotypes in patients with gastric cancer were not significantly different from healthy controls.
Conclusions: Our study provides the first evidence that rs12423190 polymorphism of the PTPN11 gene is
significantly associated with an increased risk of gastric atrophy in H. pylori infected Chinese Han population,
suggesting that rs12423190 polymorphism could be used as a useful marker of genetic susceptibility to gastric
atrophy among H. pylori infected subjects. The biological roles of this polymorphism require a further investigation.Background
Gastric cancer is the most common malignancy of
gastrointestinal tract in East Asian populations and the
third most common cause of cancer-related deaths in
China [1,2]. Helicobacter pylori (H. pylori) infection has
been established as a major risk factor for gastric cancer,
through the induction of gastric atrophy and progression
of precancerous lesions by numerous studies [3,4]. Al-
though H. pylori is estimated to inhabit at least half of* Correspondence: ccmzc32jdyycao@yahoo.com.cn
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reproduction in any medium, provided the orthe world’s human population, just few subjects develop
to gastric precancerous lesions and adenocarcinoma.
The extent of gastric damages induced by H. pylori in-
fection seems to vary from one subject to another, sug-
gesting that the combination of host genetic traits and
bacterial virulence plays important roles in long-term
outcomes of H. pylori infection [5-7].
Several studies have provided evidences that infection
with cagA-positive H. pylori associates with higher grades
of gastric inflammation and is more virulent than the
cagA-negative strains [8]. The CagA protein is delivered
into gastric epithelial cells via the bacterial type IV secre-
tion system, where it undergoes tyrosine phosphorylationtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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then acquires capability to interact with and deregulate
SHP-2 phosphatase, a bona-fide oncoprotein [9]. The for-
mation of cagA/SHP-2 complex induces abnormal prolif-
eration and migration of gastric epithelial cells,
consequently resulting in gastric atrophy and gastric car-
cinoma [10-12]. In addition, gain-of-function mutations of
the SHP-2 have recently been found in human malignan-
cies [13-15]. Kim et al also revealed that gastric cancers
displayed higher levels of SHP-2 protein compared to nor-
mal cells, suggesting that neo-expression of this signalling
protein in cells might play a role in the gastric carcinogen-
esis [16]. Since the protein-tyrosine phosphatase nonre-
ceptor-type 11 (PTPN11) gene encodes protein containing
two tandem Src homology-2 domains, which function as
phospho-tyrosine binding domains. SHP-2 closely inter-
acts with the CagA protein, therefore, it is speculated that
functional polymorphisms in the PTPN11 may mediate
the interaction of this protein with its substrates and affect
its regulatory role in various cell signalling events, such as
mitogenic activation, metabolic control, transcription
regulation, cell migration, and malignant transformation
in H. pylori infected subjects.
The PTPN11 gene is on chromosome 12, containing 16
exons. Several single–nucleotide polymorphisms (SNPs)
rs11066322, rs11066320 and rs2301756 have been identi-
fied in Caucasian females to be associated with apoB levels
and LDL-C levels [17]. Another study demonstrated that
the rs11066322 was associated with increased plasma
HDL-C levels [18]. These results suggested that genetic var-
iants influencing SHP-2 activities may modulate biological
functions of the protein. In gastric cancer, Japanese group
has found that a prevalent SNP in intron3 (rs2301756) was
associated with an increased risk of gastric atrophy in Japa-
nese population with H. pylori infection [19-22]. The aim
of the present study is to determine whether polymorph-
isms of PTPN11 gene are associated with clinical outcomes
of H. pylori infection in Chinese population.
Methods
Study populations
Four hundred and fourteen Gastric cancer cases were
selected from the department of gastric and colorectal
surgery, the First Hospital, Jilin University, from 2008 to
2010. All patients underwent tumor resection with histo-
logically confirmed diagnosis of gastric adenocarcinoma.
The gastric atrophy individuals and health controls were
recruited from the healthy check-up centre of the same
hospital from 2009 to 2010. A total 1080 persons (630
males and 450 females, aged 35 to 80 years old) partici-
pated in the study without history of cancer. The exami-
nees were Han inhabitants in Changchun city. The
informed consent was obtained from all subjects and the
study protocol was approved by the ethics committee ofthe first affiliated hospital, Jilin University. The exami-
nees received serum anti-H. pylori IgG titre and pepsin-
ogen examinations for screening H. pylori infection and
gastric atrophy.
Tests for H. pylori infection and diagnosis of gastric
Atrophy
Serum immunoglobulin (Ig) G antibodies to H. pylori
were detected by enzyme-linked immunosorbent assay
(ELISA) using H. pylori -IgG ELISA kit (Biohit, Helsink,
Finland). The antibody titres were defined by optical
density (OD) values according to the manufacturer’s
protocol and titres higher than the cut off value of
30EIU, were considered as positive for H. pylori infec-
tion. PepsinogenIand II (PGIand PGII) in serum were
measured using ELISA kits (Biohit, Helsink, Finland).
For screening gastric atrophy, we decided to use cut-off
points of <82.3 ng/ml for PGIand <6.05 for PGI/PGIIr-
atio due to no universally accepted cut-off points for
dichotomising PGI or the PGI/PGII ratio, which have
been validated against histological confirmatory studies
for gastric atrophy [23]. The kit quality control samples
showed Coefficient of variations (CVs) of 4.5, 4.3 and
4.7% for H. pylori, PGI and PGII, respectively. All sus-
pected cases with gastric atrophy by serum screening
were re-determined by endoscopic, biopsy and histo-
logical examinations for a definite diagnosis.
Selection of tagging SNPs
The principal hypothesis underlying this experiment is
that one or more common SNPs in PTPN11 gene are
associated with an altered risk of gastric atrophy and/or
gastric cancer. Thus, the aim of the SNP tagging is to
identify a set of SNPs that efficiently tags all known
SNPs. We postulate that such SNPs are also likely to tag
any hitherto unidentified SNPs in PTPN11 gene. Haplo-
type tagging SNPs (htSNPs) were selected from the Han
Chinese data in the HapMap Project (06-02-2009 HapMap)
using the SNPbrowser™ Software v4.0 to capture SNPs with
a minimum minor allele frequency (MAF) of 0.05 with a
pair-wise r square of 0.8 or greater [24]. There are 9 SNPs
at minor allele frequencies >0.05 in the PTPN11 gene in
Chinese on HapMap, all of which are located in non-
coding regions of the PTPN11 gene (Figure 1). Finally, five
htSNPs rs2301756, rs12423190, rs12229892, rs7958372 and
rs4767860 were selected and four of them are shown to be
in a complete linkage disequilibrium (LD) with Tag SNP
(D’=1 and r2 >0.8).
Genotyping
Genomic DNA from whole blood was extracted with an
AxyPrep blood Genomic DNA extraction Kit (AP-MN-
BL-GDNA-250, Axygen Biosciences, Union City, USA).
Polymerase chain reactions (PCR) were carried out on
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Figure 1 Genomic map of PTPN11 gene. Validated SNPs are illustrated and htSNPs genotyped in the present study are indicated in bold.
Vertical Lines and a box represent exons.
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master mix (Applied Biosystems). Forward and reverse
primers and FAM and VIC labelled probes were designed
by Applied Bio systems (ABI Assay-by-Designs) in a
5ul reaction. Sequences of primers and probes are avail-
able on request. Amplification conditions on BIO-RAD
S1000™ thermal cyclers (Bio-Rad Laboratories, Hercules,
California) were as follows: 1 cycle of 95°C for 10 min, fol-
lowed by 40 cycles of 95°C for 15 s and 60°C for 1 min.
The completed PCR products were read on an ABI
PRISM 7900 Sequence Detector in end-point mode using
the Allelic Discrimination Sequence Detector Software
V2.3 (Applied Biosystems). For the software to recognize
genotypes, two non-template controls were included in
each 384-well plate. All patients’ and normal control sam-
ples were arrayed together in four 384-well plates and the
fifth plate contained eight duplicate samples from each of
four plates to ensure the quality of genotyping (the con-
cordance was >99% for all SNPs).
Statistics analysis
For each polymorphism, the deviation of genotype fre-
quencies in controls from those expected under Hardy-
Weinberg equilibrium was assessed by a goodness-of-fit
x2-test. Linkage disequilibrium (LD) between pairs of
biallelic loci was determined using two measures, D’
and r2. Either Chi-square test or Fisher's exact test was
performed by comparing distributions of genotype fre-
quencies between patients and controls. Risks associated
with rare genotypes were estimated as odds ratios (ORs).
Corresponding 95% confidence intervals (CIs) by an un-
conditional logistic regression were adjusted by age
(scale variable) and sex (nominal variable). For haplo-
types with frequencies >1%, risks were compared to the
reference haplotype(major haplotype in control group)
using an unconditional logistic regression model with
the HAPSTAT 3.0 software, according to Lin et al
[Copyright (c) 2006–2008 Tammy Bailey, Danyu Lin and
the University of North Carolina, NC, USA.] [25,26].
HAPSTAT allows the user to estimate or test haplotypeeffects and haplotype-environment interactions by max-
imum likelihood estimation and the EM algorithm. All
statistical tests were two-tailed and P-values were con-
sidered to be statistically significant when ≦0.05. All
analyses were performed using a statistical analysis soft-
ware for windows, version 9.2 (SAS Institute, Cary, NC,
USA). The statistical power calculations were performed
using the QUANTO software program (Version 1.2.3).
Results
Characteristics of subject allele frequencies of the htSNPs
A total of 414 patients gastric cancer (300 males and 114
females) aged 35 to 80 years old were included in this
study. Of 1080 examinees, 148 individuals were screened
for gastric atrophy using serum PG examination; 109
patients were confirmed with gastric atrophy by biopsy
and histopathological examinations; 17 people were diag-
nosed as pseudopositive for gastric atrophy and excluded
from the study; 22 people who rejected endoscopic exam-
ination were excluded from the study. Nine hundred and
thirty-two individuals were included in the control group.
Nine persons were excluded, due to the failure to detected
anti-H. pylori Ig G and/or genotyps in blood samples. Fi-
nally, 923 subjects were included and analysed as control.
The characteristics of subjects are summarized in Table 1.
The mean age was older in gastric cancer patients than
that in controls (61.5 vs. 50.7 years; P <0.001). There were
more females in the control group (P <0.001). Prevalence
of H. pylori seropositivity were significantly higher in
groups of gastric cancer and gastric atrophy than that in
the healthy control (70.3% vs. 49.7%, P <0.001; 75.2% vs.
49.7%, P=0.01).
The linkage disequilibrium structure of the 5 poly-
morphic loci is shown in Figure 2. All D’ values are
above 0.93, and the pair-wise comparison among
rs12423190 and rs12229892 revealed a complete LDs
(jD’j= 1 and r2 = 0.285). The genotype distribution for
five htSNPs in the control group were in Hardy-Weinberg
equilibrium (P value were 0.54, 0.94, 0.78, 0.68 and
0.87 respectively). In the present study, the distribution
Table 1 Characteristics of the subjects and the PTPN11
polymorphisms
Gastric cancer Gastric atrophy Control P value
(%) (%) (%)
N 414 109 923
Sex
Male 300(72.5) 64(58.7) 539(58.4) <0.001
Female 114(27.5) 45(41.3) 384(41.6)
Age
≤45 32(7.7) 19(17.4) 276(29.9) <0.001
46-65 224(54.1) 80(73.4) 579(62.7)
>65 158(38.2) 10(9.2) 68(7.4)
Anti-H.pylori IgG
Negative 123(29.7) 27(24.8) 464(50.3) <0.001
Postive 291(70.3) 82(75.2) 459(49.7)
SNPs
rs2301756
GG 305(73.7) 86(78.9) 687(74.4) 0.462
GA 95(22.9) 22(20.2) 216(23.4)
AA 14(3.4) 1(0.9) 20(2.2)
rs12423190
TT 214(51.7) 55(50.5) 476(51.6) 0.047
TC 166(40.1) 36(33.0) 373(40.4)
CC 34(8.2) 18(16.5) 74(8.0)
rs12229892
GG 137(33.1) 40(36.7) 308(33.4) 0.963
GA 205(49.5) 50(45.9) 454(49.2)
AA 72(17.4) 19(17.4) 161(17.4)
rs7958372
TT 305(73.7) 87(79.8) 685(74.2) 0.747
TC 102(24.6) 21(19.3) 222(24.1)
CC 7(1.7) 1(0.9) 16(1.7)
rs4767860
AA 137(33.1) 39(35.8) 306(33.2) 0.386
AG 206(49.8) 44(40.4) 453(49.1)






































rs2301756A>G - 0.956 0.950 0.931 0.953
rs12423190T>C 0.036 - 1.000 0.933 0.969
rs12229892G>A 0.105 0.285 - 0.983 0.978
rs7958372T>C 0.859 0.055 0.112 - 0.971
rs4767860A>G 0.199 0.205 0.509 0.503 -
D'
r2
Figure 2 Linkage disequilibrium coefficients (|D’| and r2)
between PTPN11 htSNPs.
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different between groups (P = 0.047), however, distri-
butions of rest four SNPs were not significantly dif-
ferent between groups.
Association between htSNPs and H. pylori seropositivity,
gastric atrophy and gastric cancer
The age and sex-adjusted ORs of gastric atrophy among
H. pylori seropositive subjects were 0.93 (95%CI 0.55-
1.57, P= 0.78) for CT and 2.20 (95%CI 1.06-4.55,
P= 0.03) for CC genotype compared with rs12423190TT genotype. In a recessive model, the age- and sex-
adjusted OR was 2.47 (95%CI 1.13-4.55, P= 0.02) for CC
genotype versus rs12423190 CT/TT genotypes (Table 2).
However, the age and sex-adjusted ORs of gastric cancer
among H. pylori seropositive subjects was 1.18 (95%CI
0.64-2.18, P= 0.60) for CT and 1.30 (95%CI 0.93-1.83,
P= 0.13) for CC genotype compared with rs12423190 TT
genotype. The haplotypes with frequencies ≥1% are shown
in Table 2. The most frequent haplotypes were GTATA
(rs2301756G, rs12423190T, rs12229892A, rs7958372T,
rs4767860A) and four major haplotypes were accounted
for over 95% of distribution. There was no significant as-
sociation between haplotypes and gastric atrophy. The OR
of GCGTG haplotype was 1.36 (95%CI 0.92-2.02, P= 0.12)
versus the GTATA haplotype (Table 2). The association
between the SNPs of PTPN11 and the H. pylori infection
was examined in health controls (Table 3), but no signifi-
cant association between five htSNPs of PTPN11 and
H. pylori seropositivity was found. Distributions of
PTPN11 haplotypes were not correlated with H. pylori
seropositivity. No association between htSNPs and gastric
atrophy in H. pylori seronegative subjects was found
either (data not shown). In a subgroup analysis, we
did not find any association of htSNPs with Lauren’s
classification, tissue differentiation and TNM staging
(data not shown).
Discussions
CagA-secreting H. pylori infection plays an important
role in gastric carcinogenesis via a sequential CagA sig-
nal transduction pathway. CagA initially binds to seven
protein components to activate aberrant cellular
responses that promote the development of gastric can-
cer. Since the function of CagA protein is regulated by
its binding partners, therefore genes that encode CagA
interacting molecules may modify the risk of gastric can-
cer. In the present study, 5 htSNPs of the PTPN11 gene
were investigated for their associations with H. pylori in-
fection, gastric atrophy and gastric cancer in Chinese
Hans population. We found that subjects bearing
Table 2 PTPN11 polymorphisms among H. pylori (+) subjects
Genotype Control (%) Gastric atrophy (%) OR(95%CI)* P value Gastric cancer (%) OR(95%CI)* P value
n= 459 n= 82 n=291
rs2301756
GG 74.3 76.8 Reference 73.9 Reference
GA 23.5 22.0 0.90(0.51-1.59) 0.72 37.9 0.92(0.62-1.35) 0.66
A/A 2.2 1.2 0.51(0.06-4.09) 0.53 3.4 1.26(0.47-3.37) 0.65
rs12423190
TT 52.5 50.0 Reference 50.9 Reference
TC 40.1 34.1 0.93(0.55-1.57) 0.78 41.2 1.18(0.64-2.18) 0.60
CC 7.4 15.9 2.20(1.06-4.55) 0.03 7.9 1.30(0.93-1.83) 0.13
TT/TC 92.6 84.1 Reference 92.1 Reference
CC 7.4 15.9 2.47(1.13-4.55) 0.02 7.9 1.21(0.89-1.76) 0.15
rs12229892
GG 32.2 36.6 Reference 30.6 Reference
GA 51.2 47.6 0.82(0.49-1.39) 0.46 52.2 1.04(0.72-1.51) 0.82
AA 16.6 15.9 0.86(0.42-1.75) 0.67 17.2 1.02(0.63-1.67) 0.93
rs7958372
TT 74.1 78.0 Reference 74.2 Reference
TC 24.4 20.7 0.80(0.45-1.43) 0.46 24.1 0.94(0.64-1.37) 0.74
CC 1.5 1.2 0.83(0.10-7.01) 0.86 1.7 1.16(0.30-4047) 0.83
rs4767860
AA 33.8 34.1 Reference 31.9 Reference
AG 49.5 40.2 1.54(0.82-2.91) 0.18 51.9 1.04(0.70-1.88) 0.59
GG 16.8 25.6 0.80(0.46-1.38) 0.43 16.2 1.32(0.92-1.90) 0.14
Haplotpe
GTATA 41.3 39.6 Reference 41.2 Reference
GCGTG 26.0 32.3 1.36(0.92-2.02) 0.12 27.6 1.12(0.80-1.57) 0.51
GTGTA 16.0 14.0 0.96(0.58-1.61) 0.89 14.4 1.14(0.88-1.47) 0.32
ATGCG 12.4 11.6 1.03(0.59-1.78) 0.92 13.1 0.96(0.71-1.32) 0.82
Others 4.3 2.5 3.7
*OR for each genotype and hapolotype were calculated by age and sex adjusted logistic regression model.
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higher risk in H. pylori-seropositive gastric atrophy. The
OR for gastric cancer was increased in those carrying
the GCGTG haplotype versus the GTATA (OR=1.30,
95%CI: 0.93-1.83), however, the P value was 0.09, not
statistically significant. In this study, the allele frequen-
cies of rs12423190 were 71.8% for the T allele and 28.2%
for the C allele among control subjects. The frequency
of the C allele was similar to that reported in the HapMap
Project (31.4%). Compared to the NCBI SNP database,
we found that the frequency of the C allele is obviously
higher in Chinese population than other populations
(23.3% in Japanese; 11.5% in Utah residents with Northern
and Western European ancestry). As incidences of gastric
cancer are high in Chinese, Japanese and Koreans, high
frequencies of this polymorphism in Asian populationsmay be part of explanation. Our findings indicated that
the C allele contributes to genetic predisposition to
H. pylori-induced gastric atrophy in Chinese popula-
tion. A further study is required to confirm associa-
tions of the PTPN11 rs12423190 polymorphism with
gastric atrophy in diverse ethnic populations.
Recent studies revealed significant associations be-
tween the rs2301756 AA genotype in intron3 and
reduced risk of gastric atrophy among H. pylori-sero-
positive Japanese subjects [7,19,22]. Our study found a
similar trend of decreased risk of OR for rs2301756,
however, the OR of atrophy was not significantly lower
compared with the GA genotype (OR= 0.90, 95%CI:
0.51-1.59) and AA genotype (OR=0.51, 95%CI: 0.06-4.09).
In controversy, the association study for rs2301756 and
gastric atrophy showed a completely opposite result
Table 3 PTPN11 polymorphisms for H. pylori
seropositivity in control
Genotype Hp+ (%) Hp-(%) OR(95%CI)* P value
(n = 459) (n = 464)
rs2301756
GG 74.7 75.2 Reference
GA 23.3 22.8 1.18(0.51-2.72) 0.71
AA 2.0 2.0 1.52(0.49-4.66) 0.47
rs12423190
T/T 52.1 50.7 Reference
T/C 39.2 40.1 0.98(0.55-1.76) 0.95
C/C 8.7 9.2 0.92(0.29-2.93) 0.89
rs12229892
G/G 32.9 34.6 Reference
G/A 50.6 46.8 1.25(0.93-1.70) 0.15
A/A 16.5 18.5 1.01(0.65-1.57) 0.97
rs7958372
T/T 74.7 74.9 Reference
T/C 23.8 23.2 0.84(0.40-1.77) 0.65
C/C 1.5 1.8 0.61(0.13-2.79) 0.53
rs4767860
A/A 33.8 33.0 Reference
A/G 48.1 48.3 1.11(0.36-3.45) 0.86
G/G 18.1 18.7 1.00(0.55-1.84) 0.99
Haplotpe
GTATA 41.0 41.6 Reference
GCGTG 26.9 28.4 0.97(0.79-1.20) 0.77
GTGTA 15.7 14.8 1.08(0.83-1.40) 0.56
ATGCG 12.3 13.0 0.94(0.71-1.24) 0.66
Others 4.1 2.2
*OR for each genotype and hapolotype were calculated by age and sex
adjusted logistic regression model.
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demonstrated that the rs2301756 A allele was associated
with low risk of intestinal metastasis (IM) indicating that
H. pylori infection induces gastric precancerous lesions,
such as gastric atrophy (OR = 0.46, 95%CI: 0.21-0.99)
in H. pylori seropositive individuals. Meantime, an inverse
association was shown in H. pylori-seronegative subjects
in the same study (OR=2.51, 95%CI: 1.21-4.43) [27].
There were no statistically differences in the frequency
of rs2301756 in our study and others [21,28]. Incon-
sistent results from different studies may be due to
different environmental backgrounds and ethnic groups.
In our study, gastric atrophy was only identified in 82
cases of H. pylori- seropositive subjects, the minor al-
lele of rs2301756 was relatively rare (MAF = 0.139).
The statistical power maybe not sufficient (power= 0.10)to examine the association. A further investigation of asso-
ciation between rs2301756 and gastric atrophy is needed
in a large population and other ethnic groups.
The functions of PTPN11 polymorphisms are still un-
known. SHP-2 contains two tandem SH2 domains, a
PTP domain, and other functional motifs. Genetic muta-
tions in PTPN11 exon 3(encoding the N-SH2 domain),
exon 4(encoding the C-SH2 domain), Exons 7, 8 and 12
(encoding the PTP domain) have been identified in Noonan
syndrome, juvenile myelomonocytic leukemia, LEOPARD
syndrome, lung cancer, liver cancer and colon cancer [29].
The interaction of tyrosine phosphorylated Cag-A with
the SH2 domain of the protein is supposed to induce
a conformational change in SHP-2 that weakens the in-
hibitory interaction between PTP and N-SH2 domain, and
results in activation of SHP-2's catalytic activity [10,30].
The rs12423190 polymorphism is located in the intron 6,
1408 bp upstream exon 7, encoding part of PTP do-
main. Using a free bioinformatic tool (http://fastsnp.
ibms.sinica.edu.tw/pages/inputCandidateGeneSearch.jsp)
the rs12423190 is predicted to locate in the side of
an intronic enhancer which could affect the gene tran-
scriptional regulation. SHP-2 has several biological func-
tions. The gain-of-function of SHP-2 may accelerate the
downregulation of T-cell and B-cell activation through
CTLA-4/PD-1 as well as IL-6/STAT3 signalings, eventu-
ally leading to a decrease in inflammation. Meantime, it
might act as a signal promoter in inflammation. SHP-2
promotes growth factor induced activation of phos-
phatidylinositol 3-kinase (PI3-K)/Akt, the extracellular
signal-related kinases (ERKs) and nuclear factor-kappa
B (NF-κB). SHP-2 can either negatively or positively
regulate the activation of Janus kinase 2 (Jak2)/signal
transducer and activator of transcription (STAT) and
the c-Jun-amino terminal kinases (JNKs) depending on
different circumstances. rs12423190 may promote the
over-expression of SHP-2, further involvement in the
up-regulation of inflammatory cytokines through MAPKs
and NF-κB signaling pathways, eventually leading to
increase in inflammation related to atrophy [31]. However,
the rs2301756 does not appear to reside in transcrip-
tion factor binding sites or splicing sites, but is in
the LD with associated haplotypes. The rs12423190
polymorphism is also in a linkage disequilibrium, which
may contain other unidentified causative SNPs. Fur-
ther studies of PTPN11 sequence variants and their
biologic functions may shed light in understanding
the association of PTPN11 polymorphisms and the
risk of GA.
In addition, we demonstrated that gastric cancer
patients had high prevalence of both H. pylori seroposi-
tivity and gastric atrophy; the prevalence of H. pylori
seropositivity was significantly higher in subjects with
gastric atrophy compared to controls without gastric
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infection, gastric atrophy, and gastric cancer. Genetic
factors, such as PTPN11 polymorphisms may contribute
to gastric atrophy, through affecting the connection of
Cag A and SHP-2 protein.
The first limitation in our study is the H. pylori infec-
tion status being determined by serology, not by the
serum CagA antibody test. In East Asia countries, almost
all H. pylori strains reported from infected patients were
East Asian CagA positive strains [32-34], therefore H.
pylori strains in infected patients most likely possess
CagA in our study. The second limitation is the PG cri-
teria for GA screening, the criterion for GA is PGI
<82.3 ng/ml and PGI/II ratio <6.05. These parameters
for atrophy are used in China and have been validated in
only one histological confirmatory study [23], it is may
be insufficient to draw a reliable diagnosis, thus more
confirmatory studies are needed. Finally, a small sample
size of gastric atrophy, especially for the cohort of H.
pylori (+) gastric atrophy individuals is due to a low inci-
dence of gastric atrophy in China. A large-scale study
for recruiting more patients with gastric atrophy is
required to confirm our findings in the future.
Conclusions
In conclusion, our study provides the first evidence that
rs12423190 polymorphism of the PTPN11 gene is signifi-
cantly associated with an increased risk of gastric atrophy
in H. pylori infected Chinese population, suggesting that
rs12423190 polymorphism could be used as a biomarker
of genetic susceptibility to gastric atrophy.
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